1e
19
1
49
2
2
18
1b
1d
18
32
6e
1d
2 29
1d
25
Daniel Weintraub, MD
88
6e
Professor of Psychiatry at the Hospital of the University of Pennsylvania
28
88
3
61
Attending Physician, Hospital of the University of Pennsylvania, Philadelphia, PA
8a
Attending Physician, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA
e5
Consultant Psychiatrist, Parkinson's Disease and Movement Disorders Center (PDMDC), Hospital of the University of Pennsylvania, Philadelphia, PA (1 half-day every other week)
11
Department: Psychiatry
4
1
b
1d
46
Contact information
48
4
3
3
1d
48
University of Pennsylvania
27 Section of Geriatric Psychiatry
3a 3615 Chestnut St., #203
Philadelphia, PA 19104
26
27 Section of Geriatric Psychiatry
3a 3615 Chestnut St., #203
Philadelphia, PA 19104
31
Office: 2153498207
30 Fax: 2153498389
24
af
12
30 Fax: 2153498389
24
18
Publications
23 a
3
2
29
4
b
1f
23 a
13
Education:
21 9 B.A. 14 (History) c
42 University of North Carolina, Chapel Hill, 1985.
21 9 M.D. c
3e University of Maryland, Baltimore, MD, 1991.
c
3
3
3
3
8a
Permanent link21 9 B.A. 14 (History) c
42 University of North Carolina, Chapel Hill, 1985.
21 9 M.D. c
3e University of Maryland, Baltimore, MD, 1991.
c
2 29
21
1e
1d
24
5e
26 29
27
Description of Research Expertise
aa Parkinson's disease;Alzheimer's disease; late life mental disorders; depression; dementia; mild cognitive impairment; impulse control disorders; psychosis26 29
23
145 Cousins KAQ, Irwin DJ, Chen-Plotkin A, Shaw LM, Arezoumandan S, Lee EB, Wolk DA, Weintraub D, Spindler M, Deik A, Grossman M, Tropea TF.: Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease. Ann Clin Transl Neurol Mar 2023.
1fb Merchant KM, Simuni T, Fedler J, Caspell-Garcia C, Brumm M, Nudelman KNH, Tengstrandt E, Hsieh F, Alcalay RN, Coffey C, Chahine L, Foroud T, Singleton A, Weintraub D, Hutten S, Sherer T, Mollenhauer B, Siderowf A, Tanner C, Marek K; the Parkinson�s Progression Markers Initiative.: LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts. NPJ Parkinsons Dis 9: 30, Feb 2023.
109 Weintraub D, Gallagher J, Mamikonyan E, Xie S, Tran B, Shaw S.: Validating virtual administration of neuropsychological testing in Parkinson disease: a pilot study. Res Sq 13: 16243, Feb 2023.
175 Tropea TF, Waligorska T, Xie SX, Nasrallah IM, Cousins KAQ, Trojanowski JQ, Grossman M, Irwin DJ, Weintraub D, Lee EB, Wolk DA, Chen-Plotkin AS, Shaw LM; Alzheimer's Disease Neuroimaging Initiative.: Plasma phosphorylated tau181 predicts cognitive and functional decline. Ann Clin Transl Neurol 2023.
198 Coughlin DG, Hiniker A, Peterson C, Kim Y, Arezoumandan S, Giannini L, Pizzo D, Weintraub D, Siderowf A, Litvan I, Rissman RA, Galasko D, Hansen L, Trojanowski JQ, Lee E, Grossman M, Irwin D.: Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies. J Neuropathol Exp Neurol 81: 953-964, Nov 2022.
138 van Wamelen DJ, Rota S, Schrag A, Rizos A, Martinez-Martin P, Weintraub D, Ray Chaudhuri K.: Characterization of Non-Motor Fluctuations Using the Movement Disorder Society Non-Motor Rating Scale. Mov Disord Clin Pract 9: 932-940, Aug 2022.
1a9 Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, Clark E, Jain N, Charan R, Gallagher MD, Unger TL, Amari N, Skrinak RT, Davila-Rivera R, Brody EM, Han N, Zack R, Van Deerlin VM, Tropea TF, Luk KC, Lee EB, Weintraub D, Chen-Plotkin AS.: GPNMB confers risk for Parkinson's disease through interaction with ?-synuclein. Science 377: eabk0637, Aug 2022.
126 Liu W, Liu J, Bhavsar R, Mao T, Mamikonyan E, Raizen D, Detre JA, Weintraub D, Rao H.: Perfusion Imaging of Fatigue and Time-on-Task Effects in Patients With Parkinson's Disease. Front Aging Neurosci 14: 901203, Jun 2022.
1e5 Bl�meke L, Pils M, Kraemer-Schulien V, Dybala A, Schaffrath A, Kulawik A, Rehn F, Cousin A, Nischwitz V, Willbold J, Zack R, Tropea TF, Bujnicki T, Tamg�ney G, Weintraub D, Irwin D, Grossman M, Wolk DA, Trojanowski JQ, Bannach O, Chen-Plotkin A, Willbold D.: Quantitative detection of ?-Synuclein and Tau oligomers and other aggregates by digital single particle counting. NPJ Parkinsons Dis 8: 68, Jun 2022.
2c
7
1d
1f
Selected Publications
16c Robinson JL, Xie SX, Baer DR, Suh E, Van Deerlin VM, Loh NJ, Irwin D, McMillan CT, Wolk D, Chen-Plotkin A, Weintraub D, Schuck T, Lee VM, Trojanowski JQ, Lee EB.: Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated. Brain 146: 2557-2569, Mar 2023.145 Cousins KAQ, Irwin DJ, Chen-Plotkin A, Shaw LM, Arezoumandan S, Lee EB, Wolk DA, Weintraub D, Spindler M, Deik A, Grossman M, Tropea TF.: Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease. Ann Clin Transl Neurol Mar 2023.
1fb Merchant KM, Simuni T, Fedler J, Caspell-Garcia C, Brumm M, Nudelman KNH, Tengstrandt E, Hsieh F, Alcalay RN, Coffey C, Chahine L, Foroud T, Singleton A, Weintraub D, Hutten S, Sherer T, Mollenhauer B, Siderowf A, Tanner C, Marek K; the Parkinson�s Progression Markers Initiative.: LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts. NPJ Parkinsons Dis 9: 30, Feb 2023.
109 Weintraub D, Gallagher J, Mamikonyan E, Xie S, Tran B, Shaw S.: Validating virtual administration of neuropsychological testing in Parkinson disease: a pilot study. Res Sq 13: 16243, Feb 2023.
175 Tropea TF, Waligorska T, Xie SX, Nasrallah IM, Cousins KAQ, Trojanowski JQ, Grossman M, Irwin DJ, Weintraub D, Lee EB, Wolk DA, Chen-Plotkin AS, Shaw LM; Alzheimer's Disease Neuroimaging Initiative.: Plasma phosphorylated tau181 predicts cognitive and functional decline. Ann Clin Transl Neurol 2023.
198 Coughlin DG, Hiniker A, Peterson C, Kim Y, Arezoumandan S, Giannini L, Pizzo D, Weintraub D, Siderowf A, Litvan I, Rissman RA, Galasko D, Hansen L, Trojanowski JQ, Lee E, Grossman M, Irwin D.: Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies. J Neuropathol Exp Neurol 81: 953-964, Nov 2022.
138 van Wamelen DJ, Rota S, Schrag A, Rizos A, Martinez-Martin P, Weintraub D, Ray Chaudhuri K.: Characterization of Non-Motor Fluctuations Using the Movement Disorder Society Non-Motor Rating Scale. Mov Disord Clin Pract 9: 932-940, Aug 2022.
1a9 Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, Clark E, Jain N, Charan R, Gallagher MD, Unger TL, Amari N, Skrinak RT, Davila-Rivera R, Brody EM, Han N, Zack R, Van Deerlin VM, Tropea TF, Luk KC, Lee EB, Weintraub D, Chen-Plotkin AS.: GPNMB confers risk for Parkinson's disease through interaction with ?-synuclein. Science 377: eabk0637, Aug 2022.
126 Liu W, Liu J, Bhavsar R, Mao T, Mamikonyan E, Raizen D, Detre JA, Weintraub D, Rao H.: Perfusion Imaging of Fatigue and Time-on-Task Effects in Patients With Parkinson's Disease. Front Aging Neurosci 14: 901203, Jun 2022.
1e5 Bl�meke L, Pils M, Kraemer-Schulien V, Dybala A, Schaffrath A, Kulawik A, Rehn F, Cousin A, Nischwitz V, Willbold J, Zack R, Tropea TF, Bujnicki T, Tamg�ney G, Weintraub D, Irwin D, Grossman M, Wolk DA, Trojanowski JQ, Bannach O, Chen-Plotkin A, Willbold D.: Quantitative detection of ?-Synuclein and Tau oligomers and other aggregates by digital single particle counting. NPJ Parkinsons Dis 8: 68, Jun 2022.
2c